OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
Aline Gottlieb, Ali Canbay
Cells (2019) Vol. 8, Iss. 11, pp. 1358-1358
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Claudia Fuchs, Michael Trauner
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 432-450
Closed Access | Times Cited: 236

Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
Jing Zhong, Xiaofang He, Xinxin Gao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 48

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
María Juárez‐Fernández, David Porras, Petar Petrov, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 2001-2001
Open Access | Times Cited: 82

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
Rui Xue, Lianyong Su, Shengyi Lai, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2806-2806
Open Access | Times Cited: 57

Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
Marija Branković, Igor Jovanović, Marija Dukić, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5146-5146
Open Access | Times Cited: 40

Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7

Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice
Deming Li, Yuan‐Lu Cui, Xinjing Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 24, pp. 6829-6841
Closed Access | Times Cited: 48

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang, Yunling Tai, Derrick Zhao, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 210-210
Open Access | Times Cited: 46

Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice
Xiaoxi Li, Wenwen Zhao, Xiao Meng, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115333-115333
Closed Access | Times Cited: 34

Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway
Tetsuya Kouno, Xiao Liu, Huayi Zhao, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102056-102056
Open Access | Times Cited: 29

The Gut Microbiome and Ferroptosis in MAFLD
Jie Ji, Liwei Wu, Jue Wei, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 29

NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Alberto Nascè, Karim Gariani, François R. Jornayvaz, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1131-1131
Open Access | Times Cited: 28

Dysregulation of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis Revealed by Unbiased Profiling of Serum Metabolites
Ananta Paine, Paul S. Brookes, Soumyaroop Bhattacharya, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 1, pp. 53-63
Open Access | Times Cited: 27

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
Shuangjie Yang, Deshuai Yu, Junjie Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19

FXR and NASH: an avenue for tissue-specific regulation
Zakiyah Henry, Vik Meadows, Grace L. Guo
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 17

Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Branka Filipović, Marija Marjanovic-Haljilji, Dragana Mijač, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9132-9148
Open Access | Times Cited: 15

Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 6

Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota
Peng Shang, Moran Meng, Ping Luo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 895-895
Open Access

Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in Mice
Edward E. Cable, Jeffrey W. Stebbins, Jeff D. Johnson, et al.
PPAR Research (2025) Vol. 2025, Iss. 1
Open Access

Salidroside attenuates NASH through regulating bile acid-FXR/TGR5 signaling pathway via targeting gut microbiota
Jun Zhang, Jing Zhou, Zheyun He, et al.
International Journal of Biological Macromolecules (2025), pp. 142276-142276
Closed Access

Page 1 - Next Page

Scroll to top